Early Phase 1 Liver Cancer Trial, Recruiting NCT07242417 Sponsor: Beijing GoBroad Hospital Condition: Liver Cancer
Back to Liver Cancer

Early Phase 1 Liver Cancer Trial, Recruiting

NCT07242417
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing and able to sign a consent form agreeing to take part in the study
  • You are between 18 and 75 years old (inclusive)
  • Your doctors expect you to live for at least 12 weeks
  • You are generally well enough to carry out light activity and care for yourself (confirm with trial site for exact fitness level required)
  • Your current cancer treatment has stopped working or is not a suitable option for you
  • You have at least one area of cancer that can be measured on a scan
  • Your tumor has tested positive for a protein called GPC3, confirmed through a lab test on tumor tissue
  • Your heart, liver, kidneys, and blood counts are working well enough to take part
  • If you are able to become pregnant or father a child, you are willing to use reliable contraception during the trial
  • You have a vein suitable for a blood collection procedure called leukapheresis, where some of your blood cells are collected

Who may not be able to join:

  • Your cancer started in the brain, or you have cancer that has spread to the brain and is not currently under control
  • You have had another type of cancer in the past 5 years
  • You have an active autoimmune disease (where the immune system attacks the body) or have had one in the past
  • You have a weakened immune system, including if you are HIV positive
  • You have a condition that causes problems with blood clotting or bleeding, whether inherited or developed over time
  • You have a significant heart or blood vessel condition
  • You currently have an active infection, including tuberculosis, hepatitis C, or syphilis
  • You are currently pregnant or breastfeeding
  • You have a serious mental health condition or severe ongoing illness affecting your whole body
  • You have previously received a cell therapy or gene therapy treatment
  • You have had a severe allergic reaction to a drug in the past
  • The trial doctor believes, for any reason, that taking part would not be right for you (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: +8601050847838

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Beijing GoBroad Hospital
Registry
ClinicalTrials.gov
Start date
18 December 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Dose-Limiting Toxicities (DLT) and Maximum Tolerated Dose (MTD)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov